Geistlich FibroGide
Total Payments
$109,000
Transactions
4
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $20,000 | 1 | 0 |
| 2023 | $89,000 | 3 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $109,000 | 4 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Hard and Soft Tissue Dimensional Changes and Vascular Perfusion Around Immediately Placed Implants with or without Soft Tissue Augmentation: A 3-arm Parralles Randomized Trial | Geistlich Pharma, North America, Inc. | $75,000 | 0 |
| Ultrasonographic echontensity analysis assessing the integration of a xenogeneic collagen matrix and its induced soft tissue phenotype modification at grafted sites following root coverage procedures | Geistlich Pharma, North America, Inc. | $30,000 | 1 |
| Evaluation of Geistlich Fibro-Gide in Comparison to CTG for the Treatment Around Implants | Geistlich Pharma, North America, Inc. | $4,000 | 1 |
Top Doctors Receiving Payments for Geistlich FibroGide
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Iowa City, IA | $75,000 | 2 |
| Lorenzo Tavelli | Periodontics | Cambridge, MA | $30,000 | 1 |
| , DDS | Periodontics | Richmond, VA | $4,000 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $109,000
- Total Doctors 2
- Transactions 4
About Geistlich FibroGide
Geistlich FibroGide is a device associated with $109,000 in payments to 2 healthcare providers, recorded across 4 transactions in the CMS Open Payments database. The primary manufacturer is Geistlich Pharma, North America, Inc..
Payment data is available from 2023 to 2024. In 2024, $20,000 was paid across 1 transactions to 0 doctors.
The most common payment nature for Geistlich FibroGide is "Unspecified" ($109,000, 100.0% of total).
Geistlich FibroGide is associated with 3 research studies, including "Hard and Soft Tissue Dimensional Changes and Vascular Perfusion Around Immediately Placed Implants with or without Soft Tissue Augmentation: A 3-arm Parralles Randomized Trial" ($75,000).